Screener
Nektar Therapeutics NKTR Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Nektar Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
FAQ
- What is Nektar Therapeutics's book value per share?
- Nektar Therapeutics (NKTR) reported book value per share of $23.29 in Q1 2026.
- How has Nektar Therapeutics's book value per share changed year-over-year?
- Nektar Therapeutics's book value per share increased by 2284.5% year-over-year, from $0.98 to $23.29.
- What is the long-term trend for Nektar Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Nektar Therapeutics's book value per share has grown at a -2.5% compound annual growth rate (CAGR), from $6.03 to $5.32.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Nektar Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude